スポンサーリンク
Murakami Karindoh Hospital | 論文
- Expressions of cyclin E, A, and B1 in Hodgkin and Reed-Sternberg cells : Not suppressed by cyclin-dependent kinase inhibitor p21 expression
- Basic Fibroblast Growth Factor and Fibrosis in Hodgkin's Disease
- CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes : A possible mechanism of immune evasion in chronic active EBV infection
- Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome
- Monitoring the Expression Profiles of Doxorubicin-Resistant K562 Human Leukemia Cells by Serial Analysis of Gene Expression
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Spontaneous regression of primary breast lymphoma
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis
- Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection
- Distribution of malignant lymphoma in Japan : Analysis of 2260 cases, 2001-2006
- Estimation of apoptosis and cell proliferation in histiocytic necrotizing lymphadenitis using immunohistochemical double staining
- Atypical Lymphoplasmacytic and Immunoblastic Proliferation of Autoimmune Disease : Clinicopathologic and Immunohistochemical Study of 9 Cases
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
- A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
- Proposal for diagnostic criteria for IgG4-related kidney disease